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Abstract 
 
Growing warnings on health effects related to electronic cigarettes have met inconclusive findings 
at present. This study analyzed the in vitro percutaneous absorption of nicotine resulting by skin 
contamination with two e-liquids (refill 1 and 2) containing nicotine at 1.8%. Donor chambers of 6 
Franz
 
cells for each refill liquid were filled with 1 mL of nicotine e-liquid for 24 hours; at selected 
intervals, 1.5 mL of the receptor solutions were collected for nicotine concentration analysis by 
mean gas chromatography-mass spectrometry (LOD: 0.01 µg/ml). The experiment was repeated 
removing the nicotine donor solution after 10 minutes from the application and rinsing the skin 
surface three times with 3.0 ml of milliQ water. A total of 12 cells with 24 hours exposure and 12 
cells washed were studied. The mean concentration of nicotine in the receiving phase at the end of 
the experiment was 54.9±29.5 and 30.2 ± 18.4 µg/cm
2
 for refill 1 and 2 respectively and 
significantly lower in washed cells (4.7±2.4 and 3.5±1.3 µg/cm
2
). The skin absorption of nicotine 
can lead to minor health ilness in vapers, while caution must be paid to dermal contamination by e 
liquids in children. The skin cleaning significantly reduced the transdermal absorption kinetic and 
intradermal deposition of nicotine. 
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Introduction 
 
The explosive growth of the global electronic cigarette (e-cig) market has been accompanied by 
increasing attention to the potential health hazards of this new technology. Chemical, toxicological, 
and clinical studies are inconclusive at present, so the debate between proponents and opponents of 
e-cigs is still open (Orr MS., 2014). One of the most persuasive matters for the opposition is that the 
e-cig, originally marketed as a tobacco reduction or smoking cessation product, does not reduces 
nicotine addiction in conventional smokers (Popova et al., 2013; Grana et al., 2014); furthermore, 
use of e-cigarettes may encourage conventional cigarette use among adolescents (Dutra et al., 
2014). 
E-cigs are devices designed to deliver nicotine via the lungs by vaporization of refill liquids (e-
liquid) where nominal mean nicotine concentrations range from 0 to 3.6 % (Cameron et al., 2014); 
however Davis et al. (2014) report that 65% of products had nicotine concentration deviating for 
more than 10% from the manufacturers’ labels. 
Nicotine is a water and lipid soluble alkaloid readily absorbed through all routes of exposure. 
Poisonings caused by accidental ingestion of e-liquids containing a nicotine concentration of 1.8% 
(Basset et al., 2014) or 2.4% (Gill et al., 2015) have been reported in children. Nicotine is a weak 
base, easily absorbed through the skin (Schevelbein et al., 1972): transdermal penetration has been 
used as a smoking reduction and cessation aid in the last thirty years (Rose et al., 1984), while skin 
contamination has been reported as a pathway for intoxication in tobacco harvesting (Curwin et al., 
2005). After dermal patch application, nicotine is gradually absorbed through the skin, plasma 
levels rise slowly over 6 to 10 hours, remain at steady level for about 7 to 8 hours, and decline 
during the final 6 hours (Zevin et al., 1998). Moreover, mild systemic symptoms of nicotine 
poisoning were documented after skin contact with nicotine refill solution or leaking nicotine from 
cartridges (Cantrell and Clark, 2014). Other cases were reported in the past for unintentionally 
spilled nicotine solutions onto the skin in children (Won Kim and Baum, 1975). Recently, Maina et 
al. (2016) studied in in-vitro experiments nicotine absorption through the skin contaminated with 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
refill e-liquid, finding very low values (3.04 mg at 24 h after skin contamination of 100 cm
2
) 
compared to nicotine delivered by transdermal patches (Benowitz, 1995). 
This study aims to assess the in vitro transdermal absorption of nicotine contained in two e-
liquids marketed by different producers and the effect of a skin cleaning procedure. 
 
2. Materials and methods 
2.1 Chemicals 
All the chemicals used of analytical grade were purchased from Sigma-Aldrich Co. (St Louis, MO, 
USA). Water reagent grade was produced with a Millipore purification pack system (milliQ water). 
The physiological solution used as receptor fluid was freshly prepared by dissolving 9.00 g of NaCl, 
2.38 g of Na2HPO4 and 0.19 g of KH2PO4 into 1.00 L of milliQ water (final pH 7.35). The 
concentration of the salts in the receptor fluid was approximately the same as that present in blood. 
The two refill liquids for e-cigarettes, used as donor phase, are available in the market. The nominal 
nicotine concentration of 18 mg ml
-1
 was confirmed by gaschromatography – mass spectrometry 
(GC-MS). Both refill had pH of 7.9 and pKa of nicotine is 8.0 (Gorrod et al. 1999). 
2.2 In vitro experiments 
The experiments were performed using human cryopreserved skin (Castagnoli et al., 2003) from the 
back of three donors (two males and one female). Before use, the skin was left to thaw gradually to 
room temperature. The epidermal side of the skin was exposed to room conditions, while the dermal 
side was bathed in physiological solution. From each skin specimen, 4 cm x 4 cm pieces were cut 
and mounted separately on the diffusion cells. Each piece of skin was clamped between the donor 
and the receptor compartment; the exposed skin area was 3.29 cm
2
 and the average skin thickness 
was 0.7 mm. Skin integrity was assessed using the Trans Epidermal Water Loss (TEWL) method as 
described by Guth et al. (2015). Cells with a value >10 g m
-2
 h
-1
 were considered to be damaged and 
rejected.  
The experiments were carried out as follows: 
Experiment I: 
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Donor chambers of 6 static Franz (1975) cells (two cells for each skin donor) for each refill liquid 
were filled with 1 mL of nicotine e-liquid providing an amount of 5.5 mg of nicotine per cm
2
 of 
skin, in order to ensure an infinite dose. The receptor compartment, filled with physiological 
solution, had a mean volume of 14.0 mL and was maintained at +32°C by the circulation of 
thermostated water in the jacket that surrounds the cell. The solution in each cell was continuously 
stirred using a Teflon-coated magnetic stirrer. At selected intervals, 0.5, 1, 2, 4, 6, 8, 16, and 24 
hours, 1.5 mL of the receptor solutions were collected for nicotine concentration analysis. Each 
receptor sample was immediately replaced with an equal volume of fresh physiological solution. At 
24 h, the donor phases and the receiving solutions were removed and stored in the freezer. The skin 
samples were removed from the Franz cells, rinsed three times with 3 mL of milliQ water and then 
exposed surfaces were cut with surgical scissors and stored in the freezer for further analysis. The 
rinsing milliQ water aliquots were added to the donor phases before freezing.  
Experiment II 
A second experiment was carried out in order to mimic the washing after a contamination. The exp. 
1 was repeated but after 10 minutes from the application, the nicotine donor solutions were removed 
and the skin surfaces were rinsed three times with 3.0 mL of milliQ water. Then, 1 mL of 
physiological solution was added to each donor chamber, in order to maintain the skin in the same 
hydration conditions of the experiment I and of the blank cells (Larese et al., 2008; Nesvadbova et 
al., 2015). The washing solutions were collected for following analysis. 
Blanks 
Four cells were added as blank using physiological solution as donor solution instead of nicotine e-
liquid.  
Summarizing, the replicates were organized taking into account 3 skin donors, 2 refill liquids and 2 
different treatments, for a total of 24 exposed cells and 4 blanks. 
As the equipment used in the tests was static, there is no relationship among the cells; hence each of 
them represents an independent evaluation. 
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2.3 Analytical measurements 
Aqueous solution of nicotine was extracted with SPE C18 and eluted with methanol (1 mL). The 
recovery of the extraction, calculated from 10 standards of certified reference material (nicotine 
99%, Acros Organics) was 96,4%. The standard deviation of the measured extract was 0.3. 
Extract was analyzed with gaschromatography-mass spectrometry (Thermofisher mod. Trace-
Polaris Q) in single ion monitoring mode (ION 133 and 161). The column used was 5% phenyl-
95% Metilsilicone, 30 m length, 0.25 mm internal diameter, 0.25 µm film thickness. The injection, 
in PTV mode, for all samples was 2 µl. The sample was analyzed from 50°C to 150°C with a rate of 
5°C min
-1
 and then from 150°C to 270°C with a rate of 20°C min
-1
. 
The limit of quantification for nicotine was 0.05 µg mL
-1
 with a limit of detection of 0.01 µg mL
-1
. 
Nicotine in skin was extracted with methanol (1 mL) for 16 hours. Extract was analyzed with 
gaschromatography-mass spectrometry with the same conditions described above. 
 
2.4 Data analysis 
Nicotine concentration data (mg cm
-3
) in the receptor solution were converted to the total amount 
that permeated through the skin (mg cm
-2
), with a correction for dilution due to sampling removal. 
Flux (mass/area–time or µg cm-2 h-1) was determined for each cell from the slope of the linear part 
of the plot of cumulative chemical mass per unit area in the receptor solution over time. Lag time 
(h) was estimated as the point where the flux curve intercepts the x-axis. 
Data were reported as mean and standard deviation. Statistical differences between results in cells 
washed and not washed, donors and refills were tested by means of ANOVA. A p value of 0.05 was 
considered as significant.  
 
3. Results 
 
Table 1 summarizes the nicotine permeation data. 
Nicotine was able to permeate the skin with a flux of 2.92 ± 1.53 µg cm
-2
 h
-1
 and of 1.58 ± 0.96 µg 
cm
-2
 h
-1
 after the exposure to refill 1 and 2 solutions, respectively, with no statistical differences 
between them (replicate n. 12; F:0.5, p>0.05). Lag times were similar (F: 1.9, p>0.05) and nicotine 
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inside the skin at the end of experiments was comparable (F: 4.22, p>0.05). No differences were 
shown between donors. 
Nicotine skin absorption reduced significantly (p<0.001) after the washing procedure with a flux of 
0.29 ± 0.20 µg cm
-2
 h
-1
 and of  0.19 ± 0.07 µg cm
-2
 h
-1
 in cells treated with refill 1 and 2 solutions, 
respectively, while no differences were found for lag times between washed and non-washed cells. 
Figure 1 provides permeation profile of nicotine. Nicotine was not detectable in the receiving phase 
up to 2 hours after the start of the experiment; it slowly increased between 4 and 6 hours, then 
gradually increased reaching the concentration of 54.9 ± 29.5 and 30.2 ± 18.4 µg cm
-2 
for refill 1 
and 2 solutions treated cells, respectively. 
The permeation profile for the cleaned skin followed the same trend reaching, as expected, lower 
values at the end of the experiment (4.7±2.4 and 3.5±1.3 µg cm
-2
 for refill 1 and 2, respectively). 
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4. Discussion 
 
The main finding of this study is that nicotine can be absorbed through the skin contaminated by 
refill liquids, and that absorption is detectable also when the skin is washed for 10 minute after the 
contact with the liquid. 
From the toxicological point of view, our results are important to evaluate if skin contamination 
with e-cig refills could be dangerous for human health. The contamination of the body surface area 
due to e-liquid spilled onto the skin of the vaper can be estimated between 170 cm
2
 (area of a palm) 
and 340 cm
2
 (area of the hand), depending on the volume of the e-liquid package (10 and 20 mL, 
respectively). Taking into account that the intravenous administration of 5 mg of nicotine leads in 
adults to only minor adverse effects (coughing, and nausea) (Henningfield et al.,1983), the 
contamination of the skin area should account for 100 cm
2
 (considering our maximum results for 24 
hours penetration of 54.9 microg/cm
2
) to achieve the above toxicological level of concern. This 
result suggests that the contamination of even small skin area by e-liquid at 1.8% of nicotine can be 
associated with minor health illness. However, the area of the skin contaminated needed to cause 
the severe health effects related to the toxicological threshold value in adults (500 mg), proposed by 
Mayer (2010), is about 10000 cm
2
 (corresponding to half of the body surface): it is clear that this 
scenario is completely unrealistic. Likewise, in the case of a child of 10 Kg, where the mean 
estimated transdermal nicotine dose for symptomatic children is 1.8 g. (Wolf et al., 1997), the 
contaminated skin surface is about 30 cm
2
 (half palm). Moreover, even in the case of children, the 
contamination of the skin surface required to reach the lethal dose (70 mg) is about 20% of the 
BSA, corresponding to the area of the chest. 
Our study for the first time analyzed also the effect of the skin washed after contamination, 
adding important information on nicotine skin absorption, when a washing procedure is used after 
skin contamination. Despite the total amount of nicotine that passed through the skin is 
significalntly reduced compared to not decontaminated skin (p<0.001), the permeation profile is 
comparable to the not rinsed skin (the nicotine is detected after 2 hours following the start of the 
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experiment and continue to rise until reaching 4.05±1.08 µg cm
-2
 at the end of the experiment). This 
means that even a short contact time (10 min) produces trandermal absorption of nicotine 
suggesting the need to clean the skin as soon as possible when the contamination occurs. The 
effectiveness of the cleaning procedure was demonstrated by the absence of nicotine into the skin 
washed while nicotine was present in not cleaned skin (2.20±1.23µg cm
-2
). This finding confirms 
that the skin can act as a reservoir able to deliver nicotine. 
Results are in accord with our previous study (Maina et al., 2016) when we tested a different 
refill with lower nicotine content (0.8% vs 1.8% used in the present study), nevertheless using a 
higher nicotine concentration we obtained a lower flux through the skin. Indeed, Zorin et al. (1999) 
documented that the nicotine permeation increases in a linear relationship with its concentration in 
acqueos solutions in the range 1-10%, then we would have expected a higher nicotine skin 
absorption using a nicotine concentration of 1.8% than that obtained using a nicotine concentrations 
of 0.8%. A plausible explanation for the observed differences in nicotine fluxes magnitude could be 
related to the different characteristics of the skin used in the two experiments. It is well known that 
the percutaneous penetration of chemicals is affected by the biological characteristics of the skin 
(anatomical site, age and sex of the skin’s donor) as well as by the chemical properties of the donor 
solution made by nicotine and diluent used. A change in pH of the solution in contact with the skin 
(Nair et al., 1997) and a variation in nicotine ionization state can modify skin absorption 
(Kuswahyuning and Roberts, 2014). In addition,  nicotine permeation profile reported in  literature 
referred to aqueous solutions of nicotine, while the refill liquids contain chemicals (i.e. propylene 
glycol, flavours) that could affect absorption kinetics of the nicotine through the skin (Aungst, 
1988). 
Our study has some limitations that need to be considered. First of all, we did not considered 
nicotine metabolism that can happen into the skin, thus our results can underestimate real scenario; 
secondly, the high hydration of the skin applying 1 mL of physiological solution after the washing 
procedure can enhance nicotine skin absorption (Ishida et al., 2015), thus overestimate real 
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scenario. Moreover, it should take into account that the toxicological evaluation relies on 
experimental results claiming/ describing a worstcase scenario. Nevertheless, our study investigated 
the important topic of nicotine transdermal penetration following skin contamination in vaper, 
increasing knowledge on the widespread use of liquid nicotine and the easy contamination of the 
skin that can happen during normal procedures. 
 
 
5. Conclusions 
 
The skin absorption of nicotine can lead to minor health ilness in vapers, while caution must be 
pay to dermal contamination by e liquids in children The early cleaning of the skin further reduces 
the nicotine transdermally absorbed. 
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Figure 1: permeation profiles : means and standard deviations of nicotine amount (μg cm-2) in 
human cryopreserved skin 
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Table 1: Nicotine skin permeation data (mean ± ds) 
 Refill 1 Refill 2 
Flux (µg cm
-2
 h
-1
) 2.92 ± 1.53 1.58 ± 0.96 
0.29 ± 0.20
§
 0.19 ± 0.07
§
 
Lag time (h) 6.3 ± 1.3 6.6 ± 0.7 
5.9 ± 3.6
§
 4.4 ± 1.3
§
 
Nicotine in the skin (µg cm
-2
)^ 1.89 ± 1.36 
nd 
2.52 ± 1.27 
nd 
   
§
after rinsing procedure 
^
at the end of experiment 
nd (not detected): < LOD 
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Highlights 
 skin contamination by e-liquids containing nicotine at 1,8% leads to dermal absortpion and 
deposition of nicotine in skin 
 nicotine uptake from skin contaminated by e-liquids can lead to minor health ilness in 
vapers 
 caution must be paid to dermal contamination by e liquids in children 
 skin cleaning reduces transdermal penetration and dermal accumulation of nicotine 
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